| Issuer | % of Class | Filed |
|---|---|---|
|
Prelude Therapeutics Inc
13G/A
Amendment 6
PRLD · 74065P101
|
13.2% |
2/13/2026
Event 12/31/2025
|
|
Prelude Therapeutics Inc
13G/A
Amendment 5
PRLD · 74065P101
|
13.8% |
5/15/2025
Event 3/31/2025
|
|
Prelude Therapeutics Inc
13G/A
Amendment 4
PRLD · 74065P101
|
9.5% |
2/14/2025
Event 12/31/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.